# A Multicenter Open Clinical Study of Safety, Tolerability, Pharmacokinetic Profile, and Initial Clinical Efficacy of BAT 8010 for Injection Combined With BAT 1006 in the Treatment of Locally Advanced or Metastatic Tumors

> **NCT06376136** · PHASE1,PHASE2 · RECRUITING · sponsor: **Bio-Thera Solutions** · enrollment: 216 (estimated)

## Conditions studied

- Advanced Solid Tumors

## Interventions

- **DRUG:** BAT8010 for Injection
- **DRUG:** BAT1006 for Injection

## Key facts

- **NCT ID:** NCT06376136
- **Lead sponsor:** Bio-Thera Solutions
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-05-08
- **Primary completion:** 2026-11-09
- **Final completion:** 2026-12-09
- **Target enrollment:** 216 (ESTIMATED)
- **Last updated:** 2025-08-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06376136

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06376136, "A Multicenter Open Clinical Study of Safety, Tolerability, Pharmacokinetic Profile, and Initial Clinical Efficacy of BAT 8010 for Injection Combined With BAT 1006 in the Treatment of Locally Advanced or Metastatic Tumors". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT06376136. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*